Drug Profile
Hydrocodone/paracetamol - Mallinckrodt
Alternative Names: hydrocodone/acetaminophen - Mallinckrodt; QSC-001Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Questcor Pharmaceuticals
- Developer Adare Pharmaceuticals
- Class Acetanilides; Morphine derivatives; Non-opioid analgesics; Opioid analgesics; Small molecules
- Mechanism of Action Opioid receptor agonists; Prostaglandin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pain
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Pain in USA (PO, Tablet)
- 02 Apr 2015 Aptalis Pharmaceuticals has been acquired by TGP and renamed Adare Pharmaceuticals
- 14 Aug 2014 Questcor Pharmaceuticals has been acquired by Mallinckrodt plc